Invesaro

Stocks SLQT Financial statements

Financial statements

SelectQuote, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 9 fiscal years, taken from the XBRL data SelectQuote, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2018FY2020FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue2343375299307641,0031,3221,5271,618
Cost of revenue83.31041671.6464.2226405630731
Gross profit150233362928700777917896888
Selling, general and administrative63.1101137141164149
Selling and marketing82.1110184385484301359320314
General and administrative15.218.235.363.189.8
Operating expenses1842323777101,024928
Operating income43.296.3130192-34611.664.668.573.9
Interest expense0.931.6624.629.343.680.693.679.444.5
Other non-operating income-1.59-0.2-0.12-0.07-0.13-0.26
Pre-tax income41.594.6104158-390-69.1-29.148.576.3
Income tax6.622224.533.2-92.3-10.65.060.9314.1
Net income34.972.679.5125-298-58.5-34.147.662.2
EBITDA46.6101138208-32139.589.58991.4
EPS, basic0.300.79-0.180.77-1.81-0.35-0.200.14-0.06
EPS, diluted0.260.62-0.180.75-1.81-0.35-0.200.01-0.06
Shares, basic (weighted)72.375.997.5163164166169176188
Shares, diluted (weighted)85.711897.5166164166169182188
Dividend per share0.140.141.96

Balance sheet

FY2018FY2020FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash and equivalents0.960.5732128614183.242.732.416
Inventory0.185.755.578.76
Other current assets6.4510.14.4915.814.420.321.824.7
Total current assets103514483403363333341351
Property, plant and equipment13.822.229.541.827.51914.612.1
Lease right-of-use assets031.42823.623.424.620.5
Goodwill5.3646.66829.129.129.429.429.4
Intangible assets0.2219.740.731.310.210.21.970.84
Other non-current assets0.261.411.4418.421.63.523.883.14
Total assets4071,0741,4241,2901,2191,1941,2491,287
Accounts payable7.6322.934.124.827.636.659.274
Accrued liabilities12.622.240.942.25057.658.862.3
Deferred revenue2.021.745.083.41.698.070.7
Short-term debt2.367.1733.945.968.522
Total current liabilities33.295.8109114137175213193
Long-term debt312459698665637317348
Lease liabilities038.433.927.925.72621.8
Other non-current liabilities7.5714.611.72.992.931.8880.524.8
Total liabilities144528757899872877674637
Total debt11312461706699683385370
Paid-in capital138548545555567581572510
Retained earnings200-2.79120-177-236-270-222-160
Treasury stock-77.30
Other comprehensive income0-1.250.2311.713.74.110
Shareholders' equity187262544667391347317351352
Total equity187262544667391347317351352
Total liabilities and equity4071,0741,4241,2901,2191,1941,2491,287
Shares outstanding77.4162164164167169173176

Cash flow statement

FY2018FY2020FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Net income34.972.679.5125-298-58.5-34.147.662.2
Depreciation and amortization3.474.77.9916.124.727.92520.517.5
Stock-based compensation0.070.099.55.177.0511.313.818.414.9
Deferred income tax6.582224.433-92.8-11.21.251.5111.9
Change in receivables-6.3-8.68-13.4-20-25.7-24.85.2-5.56-15.4
Change in payables3.122.8115.719.7-4.46-3.657.3519.221.9
Cash from operations-4.850.11-61.8-115-338-19.415.2-11.731.9
Capital expenditures-5.4-3.92-9.45-14.9-24.8-1.45-3.38-2.19-4.28
Acquisitions00-35.8-41-6.930-3.4300
Cash from investing-6.02-8.64-51.4-64-42.6-9.13-14.8-11.3-16.1
Stock issued0.574.35.511.893.181.190.080.10
Share buybacks-0.44-0.0300
Dividends paid-1.88-1.96-27500
Cash from financing11.58.1448197235-29.3-40.917.4-31.1
Net change in cash0.62-0.39368-82.4-145-57.8-40.5-5.62-15.4
Free cash flow-10.2-3.81-71.2-130-363-20.811.9-13.927.6
Interest paid0.791.4723.52638596760.637.2
Income taxes paid0.040.040.06-0.21-0.17-0.310.593.16-0.19

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to September 30, 2026; growth uses fiscal years. Valuation uses the share price of $0.46 on November 10, 2026.

Profitability

MetricValueHow it is calculated
Gross margin55.8%Gross profit / revenue.
Operating margin5.5%Operating income / revenue.
EBITDA margin6.6%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin5.6%Pre-tax income / revenue.
Net margin4.6%Net income / revenue.
FCF margin2.1%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin2.3%Cash from operations / revenue.
Effective tax rate17.3%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)23.1%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)5.8%Net income / average total assets.
Return on invested capital (ROIC)10.3%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue9.5%Selling, general and administrative expense / revenue.
Stock-based pay / revenue0.8%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue0.2%Capital expenditures / revenue.
D&A / revenue1.1%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y6.0%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y17.3%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y11.7%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y-0.9%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y4.5%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y-0.9%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y7.9%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y85.5%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y-17.4%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y2.8%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y32.3%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y-15.2%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y30.7%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 5y-13.0%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y-700.0%EPS vs the same period a year earlier. Only from a positive base.
Book value growth, 1y0.2%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y0.5%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y-12.0%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y3.0%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y1.8%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-2.0%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y3.5%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y4.2%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y2.6%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio2.00xCurrent assets / current liabilities.
Quick ratio0.05x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.05x(Cash + short-term investments) / current liabilities.
Debt / equity1.23xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets30.8%Total debt / total assets.
Liabilities / assets49.6%Total liabilities / total assets.
Net debt$376.1MTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA3.63xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage1.97xOperating income / interest expense.
Working capital$182.7MCurrent assets - current liabilities.
Goodwill and intangibles / assets2.4%(Goodwill + intangible assets) / total assets.
Tangible book value$283.0MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.25xRevenue / average total assets.
Fixed asset turnover145xRevenue / average property, plant and equipment.
Days payables31 days365 x average accounts payable / cost of revenue.
FCF conversion44.9%Free cash flow / net income, when net income is positive.
Capex / operating cash flow10.7%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$0.38Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$8.20Revenue / diluted weighted shares.
FCF per share$0.17Free cash flow / diluted weighted shares.
Operating cash flow per share$0.19Cash from operations / diluted weighted shares.
Book value per share$1.74Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$1.58Tangible book value / shares outstanding.
Cash per share$0.05(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$80.8MShare price x shares outstanding.
Enterprise value$456.9MMarket cap + total debt - cash - short-term investments.
P/E1.12xMarket cap / net income. Only when net income is positive.
P/S0.05xMarket cap / revenue.
P/B0.26xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book0.29xMarket cap / tangible book value, when positive.
P/FCF2.49xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF2.22xMarket cap / cash from operations, when positive.
EV/Sales0.29xEnterprise value / revenue.
EV/EBIT5.31xEnterprise value / operating income, when both are positive.
EV/EBITDA4.40xEnterprise value / EBITDA, when both are positive.
EV/FCF14.1xEnterprise value / free cash flow, when both are positive.
FCF yield40.2%Free cash flow / market cap.
Earnings yield89.5%Net income / market cap (the inverse of P/E).
What was SelectQuote, Inc.'s revenue in fiscal 2026?

SelectQuote, Inc. reported revenue of $1.62B for fiscal 2026, 6% higher than the year before.

Was SelectQuote, Inc. profitable in fiscal 2026?

Yes. Net income was $62.2M, a net margin of 3.8%.

How much free cash flow did SelectQuote, Inc. generate in fiscal 2026?

Cash from operations of $31.9M minus capital expenditures of $4.3M left free cash flow of $27.6M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to SelectQuote, Inc.